OMRON Healthcare, who specialise in remote blood pressure monitoring and personal health technology, highlighted its new remote patient monitoring services at the 2022 Consumer Electronics Show (CES) and won "Best of" honours for its programs in the U.S. and the U.K.
VitalSight by OMRON in the U.S. was recognised as an INSIDER "Best of" CES selection, and Hypertension Plus by OMRON in the U.K. was selected as a TWICE Picks Awards winner for the 2022 TWICE, Residential Systems, and TechRadar Pro Picks Awards.
OMRON remote patient monitoring services gained attention and recognition as breakthrough health technologies designed to foster greater active health condition management, strengthen the patient-physician connection, and guide behaviour change to reduce health risks and advance the company's mission of Going for Zero, the elimination of heart attack and stroke.
Andre Van Gils, senior general manager, global sales & marketing and executive officer of OMRON Healthcare – Japan, said:
"VitalSight was designed to help the 37 million Americans who have uncontrolled Stage 2 hypertension and live every day with a higher risk of heart attack and stroke, and OMRON developed Hypertension Plus as the first step toward transforming chronic care in the U.K.”
VitalSight is the first remote patient monitoring service from OMRON Healthcare, a service that a physician can offer to patients with high-risk levels of hypertension. Patients receive a kit delivered to their home that includes an OMRON connected blood pressure monitor and data hub that are pre-set to securely share measurements – digitally – with the patient's physician and care team. The VitalSight data hub, which can be used at home without Wi-Fi or cellular connection, garnered attention at CES for bridging healthcare gaps for patients in under-resourced communities.
Insider recognised VitalSight by OMRON on its list of 13 most exciting health, home, and kitchen products of CES 2022. The list brought together high-tech concepts and new products – unveiled at CES 2022 – that you can buy now or later in 2022. Insider cited VitalSight among the "Best of" CES as "life-saving technology" and "great technology for patients who can't see their doctor regularly because of location, finances, or mobility concerns."
Hypertension Plus by OMRON is providing a way for patients to manage hypertension and connecting them to their physicians and care teams in the U.K. The service provides an app that enables patients to work remotely with their physicians to manage their conditions. Medication decisions and actions are communicated to users through the app, while automated reminders and scheduled condition management actions keep the patient engaged in treatment. Hypertension Plus by OMRON is based on the TASMINH research studies, which demonstrated that significant reductions in blood pressure can occur through remote monitoring titration – as represented in Hypertension Plus.
